Supporters of a long-awaited measure that would establish a board to review and regulate statewide prescription drug prices are hoping to gain momentum for the bill to pass this spring.
Contained in House Bill 1443 and Senate Bill 66, the measure would establish a Health Care Availability and Access Board with the power to review certain prescription drugs and set a maximum price if it finds that the given drug presents “affordability challenges”.
Renewed calls for the initiative, known also as a prescription drug affordability board echoed throughout the capitol rotunda last week.
First introduced in January 2025, both bills are still awaiting committee assignments, signaling they are a long way from becoming law.
